Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Protein identification in purified amyloid fibrils

ABSTRACT: We identified the protein in purified AL amyloid fibrils extracted from heart tissues from transgenic mice developing AL amyloidosis.

INSTRUMENT(S):

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Heart

SUBMITTER: Emilie Pinault

LAB HEAD: Christophe Sirac

PROVIDER: PXD059000 | Pride | 2025-01-17

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	Ex_vivo_fibrils_Heart_SAI_1187-7049_DDA_std_1ul_2003.d.zip	Other
	Ex_vivo_fibrils_Heart_SAI_1187-7049_DDA_std_1ul_2003.xlsx	Xlsx
	Ex_vivo_fibrils_Heart_SAI_1187-7049_DDA_std_1ul_2003_6.1.331.mgf	Mgf
	Ex_vivo_fibrils_Heart_SAI_4153-7519_DDA_std_1ul_2058.d.zip	Other
	Ex_vivo_fibrils_Heart_SAI_4153-7519_DDA_std_1ul_2058.xlsx	Xlsx

Items per page:

1 - 5 of 9

Similar Datasets

A mouse model of cardiac AL amyloidosis unveils mechanisms of tissue accumulation and toxicity of amyloid fibrils

Project description:Immunoglobulin light chain (LC) amyloidosis (AL) is one of the most common types of systemic amyloidosis. The lack of reliable in vivo models hinders the study of the disease in its physiological context. We developped a transgenic mouse model producing high amounts of a human AL free light chain (LC). While mice exceptionnaly develop spontaneous AL amyloidosis and do not exhibit organ toxicity due to the circulating amyloidogenic LC, a single injection of amyloid fibrils, made up of the variable domain (VL) of the human LC, or soluble VL led to amyloid deposits, mainly in heart. The biochemical composition and the fragmentation pattern of the LC in the fibrils are highly similar to that of human AL fibrils, arguing for a conserved mechanism of amyloid fibrils formation. Amyloidosis positive mice also develop an early cardiac dysfunction, with increased NT-proBNP, diastolic dysfunction and remodeling of the extracellular matrix. Overall, this transgenic mice closely reproduces human cardiac AL amyloidosis and shows that a partial degradation of the LC initiate amyloid fibril formations in vivo. Accumulation of AL amyloid fibrils, rather than the soluble LC, drive the initial cardiac dysfunction. This model fills an important gap for research on AL amyloidosis and preclinical evaluation of new therapies.

2025-01-17 | GSE286368 | GEO

Sequence of amyloid fibrils from renal AL amyloidosis

Project description:De novo sequencing of amyloid fibrils from renal AL amyloidosis based on LC-MS/MS

2025-07-25 | PXD066587 |

A mouse model of cardiac AL amyloidosis unveils mechanisms of tissue accumulation and toxicity of amyloid fibrils

Project description:A mouse model of cardiac AL amyloidosis unveils mechanisms of tissue accumulation and toxicity of amyloid fibrils

2025-01-17 | PXD059046 | Pride

Helical superstructures between amyloid and collagen VI in heart derived fibrils from a patient with Light Chain Amyloidosis

Project description:we investigated the N-glycosylation of the amyloid fibrils extracted from the heart of a patient affected by AL amyloidosis, using a proteomic approach to evaluate indirectly the presence of glycans in immunoglobulin light chains.

2024-07-02 | PXD049369 | Pride

Single cell and clonal analysis of AL amyloidosis plasma cells and their bone marrow microenvironment

Project description:AL amyloidosis is a disorder characterized by expansion of clonal plasma cells in the bone marrow and distant end organ damage mediated by misfolded immunoglobulin free light chains. There are currently limited data regarding the functional characteristics of AL amyloidosis plasma cells and their surrounding bone marrow microenvironment. We performed 5’ single cell RNA sequencing on 9 newly diagnosed, treatment naive AL amyloidosis patients and 8 healthy subjects. We identified generalized suppression of normal bone marrow hematopoiesis with distinct expansion of CD16 monocytes and subsets of CD4+ T cells in AL amyloidosis patients. We detected significant transcriptional changes broadly occurring among immune cells with increased interferon α and γ response and decreased TNF-α signaling. T and B cell receptor profiling revealed no overt clonal expansion of B or T cells in AL amyloidosis patients. However, we noted a disproportionate expansion of a distinct population of non-malignant plasma cells in AL amyloidosis patients. Finally, clonal AL amyloidosis plasma cells were identified based on their unique VDJ rearrangement and they showed increased expression of genes involved in proteostasis and antigen processing when compared to autologous, polyclonal plasma cells. Inter-patient transcriptional heterogeneity was evident, with transcriptional states reflective of common genomic translocations easily identifiable. Overall, this study defines the transcriptional characteristics of AL amyloidosis plasma cells and their surrounding bone marrow microenvironment, identifying transcriptional signatures that serve as candidates in early diagnosis in larger studies, and potential molecular targets for therapy.

2025-03-18 | GSE292189 | GEO

Light chain amyloid fibrils from an AL amyloidosis patient (case 1), abdominal fat biopsy

Project description:In this study, we successfully extracted and resolved the high-resolution structure of amyloid fibrils from biopsy sample obtained from a living AL patient using cryo-EM.

2025-12-23 | PXD065430 | Pride

Light chain amyloid fibrils from an AL amyloidosis patient (case 3), abdominal fat biopsy

Project description:In this study, we successfully extracted and resolved the high-resolution structure of amyloid fibrils from abdominal fat biopsy sample obtained from a living AL patient using cryo-EM.

2025-12-23 | PXD065432 | Pride

Light chain amyloid fibrils from an AL amyloidosis patient (case 2), abdominal fat biopsy

2025-12-23 | PXD065431 | Pride

Helical superstructures between amyloid and collagen VI in heart derived fibrils from a patient with Light Chain Amyloidosis

Project description:We investigated the N- and C-terminome of the LCs proteoforms in fibrils extracted from the hearts of a patient affected by AL amyloidosis, using a proteomic approach based on N- and C-terminal residues derivatization, followed by mapping of fragmentation sites on the structures of fibrillar LCs

2024-07-02 | PXD049301 | Pride

Cryo-EM of cardiac AL-224L amyloid reveals shared features in l6 light chain fibril folds

Project description:Structural characterization of an amyloid fibril from a patient afected by cardiac light chain amyloidosis.

2026-01-23 | PXD064296 | Pride